l-Histidine-based pH-sensitive anticancer drug carrier micelle: Reconstitution and brief evaluation of its systemic toxicity
- 13 March 2008
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 358 (1-2) , 177-183
- https://doi.org/10.1016/j.ijpharm.2008.03.003
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Tumor pH-responsive flower-like micelles of poly(l-lactic acid)-b-poly(ethylene glycol)-b-poly(l-histidine)Published by Elsevier ,2007
- Targeting multidrug resistance in cancerNature Reviews Drug Discovery, 2006
- Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumorJournal of Controlled Release, 2005
- Drug Delivery Systems: Entering the MainstreamScience, 2004
- Sulfonamide based pH-sensitive polymeric micelles: physicochemical characteristics and pH-dependent aggregationColloids and Surfaces A: Physicochemical and Engineering Aspects, 2003
- Pharmacokinetics of Pegylated Liposomal DoxorubicinClinical Pharmacokinetics, 2003
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- Superior therapeutic efficacy of N-l-leucyl-doxorubicin versus doxorubicin in human melanoma xenografts correlates with higher tumour concentrations of free drugEuropean Journal Of Cancer, 1999
- The antitumour activity of the prodrug N-l-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenograftsEuropean Journal Of Cancer, 1998
- Doxorubicin compared with related compounds in a nude mouse model for human ovarian cancerEuropean Journal of Cancer and Clinical Oncology, 1990